Diastolic Heart Failure Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
The diastolic heart failure clinical trial market research report provides an overview of diastolic heart failure clinical trials scenario. The report provides top line data relating to the clinical trials on diastolic heart failure. It also includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. Moreover, the report also offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type.
Diastolic Heart Failure Clinical Trials Market Segmentation by Regions and Countries
The key regions in the diastolic heart failure clinical trials market are North America, Asia-Pacific, Europe, Middle East and Africa, and South and Central America.
In a country wise analysis, as of April 2022, the US has the highest number of diastolic heart failure clinical trials, followed by Germany, Japan, China, United Kingdom, Canada, Spain, Russia, Italy, and Netherlands.
G7 countries: Among the G7 (United States, United Kingdom, Germany, France, Italy, Canada, and Japan) countries, the US has the highest proportion of diastolic heart failure to cardiovascular clinical trials as of April 2022. Moreover, most of the clinical trials were conducted in the US.
E7 countries: Among the E7 (Brazil, Russia, India, China, Mexico, Turkey, and Indonesia) countries, Mexico has the highest proportion of diastolic heart failure to cardiovascular clinical trials as of April 2022. Out of all the clinical trials conducted in the E7 countries, the majority were in China.
Diastolic Heart Failure Clinical Trials Analysis by Regions
For more regional insights into the diastolic heart failure clinical trials market, download a free report sample
Diastolic Heart Failure Clinical Trials Market Segmentation by Sponsor Types
The key sponsor types in the diastolic heart failure clinical trials market are institution, company, and government. Out of them, institution dominates the market.
Diastolic Heart Failure Clinical Trials Market Analysis by Sponsor Types
For more sponsor type insights into the diastolic heart failure clinical trials market, download a free report sample
Diastolic Heart Failure Clinical Trials Market - Competitive Landscape
The leading sponsors in the diastolic heart failure clinical trials market are AstraZeneca Plc, Novartis AG, Bayer AG, C. H. Boehringer Sohn AG & Co KG, Eli Lilly and Co, Johnson & Johnson, Pamplona Capital Management LLP, Gilead Sciences Inc, Cyclerion Therapeutics Inc, and Abbott Laboratories. Out of them, AstraZeneca Plc has conducted the highest number of diastolic heart failure clinical trials.
Diastolic Heart Failure Clinical Trials Market Analysis by Sponsors
To know more about the leading players in the diastolic heart failure clinical trials market, download a free report sample
Diastolic Heart Failure Clinical Trials Market Report Overview
Key Regions | North America, Asia-Pacific, Europe, Middle East and Africa, and South and Central America |
Key Countries | The US, Germany, Japan, China, United Kingdom, Canada, Spain, Russia, Italy, and Netherlands |
Key Sponsor Types | Institution, Company, and Government |
Leading Sponsors | AstraZeneca Plc, Novartis AG, Bayer AG, C. H. Boehringer Sohn AG & Co KG, Eli Lilly and Co, Johnson & Johnson, Pamplona Capital Management LLP, Gilead Sciences Inc, Cyclerion Therapeutics Inc, and Abbott Laboratories |
Scope
- The report provides a snapshot of the global clinical trials landscape.
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status.
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company.
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment.
- The Report provides enrollment trends for the past five years.
- Report provides latest news for the past three months.
Reasons to Buy
- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
Novartis AG
Bayer AG
C. H. Boehringer Sohn AG & Co KG
Eli Lilly and Co
Johnson & Johnson
Abbott Laboratories
Cyclerion Therapeutics Inc
Gilead Sciences Inc
Pamplona Capital Management LLP
Table of Contents
Frequently asked questions
-
What are the key regions in the diastolic heart failure clinical trials market?
The key regions in the diastolic heart failure clinical trials market are North America, Asia-Pacific, Europe, Middle East and Africa, and South and Central America.
-
What are the key countries in the diastolic heart failure clinical trials market?
The key countries in the diastolic heart failure clinical trials market are the US, Germany, Japan, China, United Kingdom, Canada, Spain, Russia, Italy, and Netherlands.
-
What are the key sponsor types in the diastolic heart failure clinical trials market?
The key sponsor types in the diastolic heart failure clinical trials market are institution, company, and the government.
-
Who are the leading sponsors in the diastolic heart failure clinical trials market?
The leading sponsors in the diastolic heart failure trials market are AstraZeneca Plc, Novartis AG, Bayer AG, C. H. Boehringer Sohn AG & Co KG, Eli Lilly and Co, Johnson & Johnson, Pamplona Capital Management LLP, Gilead Sciences Inc, Cyclerion Therapeutics Inc, and Abbott Laboratories.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.
Related reports
View more Cardiovascular reports

